Journal article
Synthetic cannabinoids: A review of the clinical implications of a new drug of choice
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, v 30(11), pp 1-4
01 Nov 2017
PMID: 29064946
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Synthetic marijuana use is an emerging public health problem in the United States, and can cause agitation, severe psychosis, bizarre hallucinations, and possibly death. This article describes these products, which are unregulated and can vary widely in composition, and how clinicians can recognize patients with synthetic cannabinoid toxicity and treat them appropriately to minimize morbidity and mortality.
Metrics
Details
- Title
- Synthetic cannabinoids: A review of the clinical implications of a new drug of choice
- Creators
- Shaina A. Freund - NewYork–Presbyterian HospitalAdrian S. Banning - Drexel University
- Publication Details
- JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, v 30(11), pp 1-4
- Publisher
- Lippincott Williams & Wilkins
- Number of pages
- 4
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Physician Assistant
- Web of Science ID
- WOS:000419295300007
- Scopus ID
- 2-s2.0-85031307018
- Other Identifier
- 991019168481704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Psychiatry